Tamar Polonsky to Walking
This is a "connection" page, showing publications Tamar Polonsky has written about Walking.
Connection Strength
3.962
-
Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical Trial. JAMA. 2026 Feb 03; 335(5):407-415.
Score: 0.863
-
Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy. J Am Heart Assoc. 2021 06 15; 10(12):e017609.
Score: 0.624
-
Durability of Benefits From Supervised Treadmill Exercise in People With Peripheral Artery Disease. J Am Heart Assoc. 2019 01 08; 8(1):e009380.
Score: 0.528
-
Duration of Supervised Exercise Necessary for Meaningful Improvement in Peripheral Artery Disease. J Am Heart Assoc. 2025 09 16; 14(18):e040058.
Score: 0.210
-
Hepatocyte growth factor for walking performance in peripheral artery disease. J Vasc Surg. 2025 06; 81(6):1467-1478.e1.
Score: 0.200
-
Discordance of patient-reported outcome measures with objectively assessed walking decline in peripheral artery disease. J Vasc Surg. 2024 04; 79(4):893-903.
Score: 0.186
-
Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial. JAMA. 2021 04 06; 325(13):1266-1276.
Score: 0.154
-
Meaningful change in 6-minute walk in people with peripheral artery disease. J Vasc Surg. 2021 01; 73(1):267-276.e1.
Score: 0.144
-
Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial. Circ Res. 2020 02 28; 126(5):589-599.
Score: 0.143
-
Racial Differences in the Effect of Granulocyte Macrophage Colony-Stimulating Factor on Improved Walking Distance in Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. J Am Heart Assoc. 2019 01 22; 8(2):e011001.
Score: 0.132
-
Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial. JAMA. 2018 04 24; 319(16):1665-1676.
Score: 0.126
-
High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics. Atherosclerosis. 2014 Nov; 237(1):169-76.
Score: 0.098
-
Community-based recruitment with ankle brachial index testing to identify peripheral artery disease participants for randomized clinical trials. Am Heart J. 2026 Oct; 300:107450.
Score: 0.055
-
The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease. Vasc Med. 2024 12; 29(6):640-652.
Score: 0.049
-
Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis. JAMA Netw Open. 2023 09 05; 6(9):e2334590.
Score: 0.046
-
Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial. J Am Heart Assoc. 2023 09 05; 12(17):e031182.
Score: 0.046
-
Hospitalizations during home-based walking exercise interventions in peripheral artery disease: Results from two randomized clinical trials. Vasc Med. 2023 12; 28(6):583-585.
Score: 0.046
-
Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021. Vasc Med. 2023 04; 28(2):144-146.
Score: 0.044
-
Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial. JAMA. 2022 10 04; 328(13):1315-1325.
Score: 0.043
-
Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. J Vasc Surg. 2023 Feb; 77(2):506-514.
Score: 0.043
-
Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical Trial. J Am Heart Assoc. 2022 08 02; 11(15):e025063.
Score: 0.042
-
Sustained physical activity in peripheral artery disease: Associations with disease severity, functional performance, health-related quality of life, and subsequent serious adverse events in the LITE randomized clinical trial. Vasc Med. 2021 10; 26(5):497-506.
Score: 0.039
-
Associations of Poly (ADP-Ribose) Polymerase1 abundance in calf skeletal muscle with walking performance in peripheral artery disease. Exp Gerontol. 2020 10 15; 140:111048.
Score: 0.037
-
Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy. J Am Heart Assoc. 2020 04 07; 9(7):e015197.
Score: 0.036
-
Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. JAMA. 2017 12 05; 318(21):2089-2098.
Score: 0.031